Through our venture philanthropy model, we provide early stage funding to companies to develop breakthrough drugs for adults and children with cystic fibrosis.
Site Search
Learn about our focus for 2020-2024 as we advance our path to a cure, meet emerging challenges in care, and explore new ways to partner with and support the CF community.
Engaging with biotechnology and pharmaceutical companies is essential to reaching our goal of a cure for all people with cystic fibrosis. These principles and standards for Industry interactions safeguard our independence, objectivity, and ability to make decisions that are in the best interest of people with CF.
The Cystic Fibrosis Foundation would like to recognize and thank the following members of the CF community for providing their time, expertise, and insights to inform the content on this site.
The Cystic Fibrosis Foundation has an attendance policy for all Foundation events, meetings, and offices to preserve the health and well-being of all people, including people with cystic fibrosis, by reducing the risk of getting and spreading dangerous germs.
By using or visiting the website, services, mobile applications, or content provided by www.cff.org (“Site”), a service of the Cystic Fibrosis Foundation (“CFF”), including auction.cff.org, you are agreeing to be bound by the following Terms of Agreement (“Terms”). If you don't agree to these Terms, you may not register, visit, or use the Site.
The Cystic Fibrosis Foundation is the world's leader in the search for a cure for cystic fibrosis. Join the team that’s adding tomorrows.
Learn more about our Board and Officer Conflict of Interest Policy.
Learn more about the Cystic Fibrosis Foundation’s Code of Ethics.
As a highly committed National Corporate Champion — Daugherty employees have been involved for nearly 15 years and have raised more than $275,000 to help advance the Foundation’s mission. Their steadfast support continues to fuel some of the most innovative CF research in the world.